Dr. Mi-Hua Tao
Executive Officer, Division of Nucleic Acid Therapy, Biomedical Translation Research Center , Academia Sinica.
Distinguished Research Fellow of the Institute of Biomedical Sciences, Academia Sinica.
🕿 (02)7750-5578
🖂 bmtao@ibms.sinica.edu.tw
🌐 Website
Highlights
Immunological tolerance is a common feature of chronic viral infections and malignant diseases. The research focus of my laboratory is to understand immunosuppressive mechanisms present in chronic hepatitis B (HBV) infections and in tumor microenvironment, and to develop novel therapeutic strategies to overcome immunosuppression and reactivate virus- and tumor-specific immunity for cure of chronic HBV and HBV-associated hepatocellular carcinoma and other cancers. For HBV studies, we have developed several HBV animal models, including HBV transgenic mice, human liver mice and human immune system mice (generated, respectively, by transplantation of human hepatocytes and/or human hematopoietic stem cells), and HBV pseudoviruses. For cancer immunotherapies, we have developed orthotopic liver cancer model, liver metastasis model of colon cancer, and oncogene-driven spontaneous breast cancer model to evaluate the therapeutic efficacy. Since outbreak of COVID-19 pandemic, we are actively engaged in developing COVID-19 vaccines (mRNA and recombinant RBD) and has transferred the technology to industry. We also developed COVID-19 animal models to help researchers and biotech companies to evaluate efficacy of their drugs, antibodies or vaccines against SARS-CoV-2 infection.
Academic Appointments
- 2026/04- Executive Officer, Division of Nucleic Acid Therapy, Biomedical Translation Research Center
- 2025/07- Distinguished Research Fellow, IBMS, Academia Sinica
- 2019/09-2026/04 Executive Officer, Translational Medicine Division, Biomedical Translation Research Center
- 2019/03- Member, Academia Sinica Ethics Governance Committee on Taiwan Biobank
- 2019/02- Chairperson, IBMS Animal Committee
- 2019/02- Chairperson, Academia Sinica SPF Animal Facility Committee
- 2018/10- Member, Academia Sinica IRB on Biomedical Research
- 2007- Adjunct Professor, National Yang-Ming University
- 2006-2008 Deputy Director, IBMS, Academia Sinica
- 2004- Adjunct Professor, Department of Clinical Laboratory Sciences and Medical Technology , National Taiwan University
- 2004- Adjunct Professor, Graduate Institute of Life Sciences, National Defense Medical University
- 2004/02-2025/07 Research Fellow, IBMS, Academia Sinica
- 1990-1993 Postdoctoral fellow (Oncology) Stanford University
- 1985-1990 M. Ph. (Microbiology/Immunology), Columbia University
- 1979-1983 B.A. (Medical Technology), National Taiwan University
Awards and Honors
- 2022/07, Excellence in Medical Technology Award of the 18th Tien Te Lee Biomedical Awards.
- 2010/06, NIH, USA R21 grant award.
- 2003/05, Outstanding Research Award, National Science Council, Taiwan.
- 2001, ISI Citation Classic Award for “Most-Cited Papers” from 1981-1999 in Taiwan.
- 2000/01, Outstanding Research Award, National Science Council, Taiwan.
- 1999, Research Award for Junior Research Investigators, Academia Sinica, Taipei, Taiwan.
